arginine vasopressin has been researched along with Cognition Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Q; Yang, C; Yang, Z; Zhang, T; Zhang, X | 1 |
| Curley, J; Raber, J; Rizk, A; Robertson, J | 1 |
| Ebert, M; Gillin, JC; Gold, P; Kaye, W; Peterson, R; Smallberg, S; Weingartner, H | 1 |
| Berger, PA; Kopell, BS; Pigache, R; Tinklenberg, JR | 1 |
| Altemus, M; Davis, CL; Gold, PW; L'Heureux, F; Murphy, DL; Pigott, T; Rubinow, DR | 1 |
| Bohnen, NI; Jolles, J; Twijnstra, A | 1 |
| Raber, J | 1 |
1 review(s) available for arginine vasopressin and Cognition Disorders
| Article | Year |
|---|---|
Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits.
Topics: Acquired Immunodeficiency Syndrome; Adrenocorticotropic Hormone; Amygdala; Animals; Arginine Vasopressin; Aspartic Acid; Chronic Disease; Cognition Disorders; Corticotropin-Releasing Hormone; Feedback; Glucocorticoids; Glutamic Acid; Hippocampus; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Memory Disorders; Mice; Models, Biological; Obesity; Pituitary-Adrenal System; Rats; Stress, Physiological; Synaptic Transmission | 1998 |
2 trial(s) available for arginine vasopressin and Cognition Disorders
| Article | Year |
|---|---|
Vasopressin treatment of cognitive dysfunction in progressive dementia.
Topics: Arginine Vasopressin; Clinical Trials as Topic; Cognition Disorders; Deamino Arginine Vasopressin; Dementia; Female; Humans; Male; Middle Aged; Placebos | 1981 |
A controlled trial with vasopressin analogue (DGAVP) on cognitive recovery immediately after head trauma.
Topics: Adolescent; Adult; Aged; Arginine Vasopressin; Cognition Disorders; Craniocerebral Trauma; Double-Blind Method; Female; Humans; Male; Middle Aged | 1993 |
4 other study(ies) available for arginine vasopressin and Cognition Disorders
| Article | Year |
|---|---|
Arginine vasopressin attenuates dysfunction of hippocampal theta and gamma oscillations in chronic cerebral hypoperfusion via V1a receptor.
Topics: Animals; Arginine Vasopressin; Brain; Brain Ischemia; Cerebrovascular Circulation; Cognition Disorders; Gamma Rhythm; Hippocampus; Male; Maze Learning; Rats; Rats, Wistar; Receptors, Vasopressin; Spatial Learning; Temporal Lobe; Theta Rhythm | 2019 |
Anxiety and cognition in histamine H3 receptor-/- mice.
Topics: Amygdala; Animals; Anxiety; Arginine Vasopressin; Behavior, Animal; Cognition; Cognition Disorders; Dose-Response Relationship, Radiation; Exploratory Behavior; Immunohistochemistry; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Psychomotor Performance; Reaction Time; Receptors, Histamine H3; Reflex, Acoustic; Spatial Behavior; Statistics, Nonparametric; Time Factors | 2004 |
Desglycinamide-9-arginine-8-vasopressin (DGAVP, Organon 5667) in cognitively impaired patients.
Topics: Aged; Arginine Vasopressin; Cognition Disorders; Humans; Male; Middle Aged | 1982 |
CSF somatostatin in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Arginine Vasopressin; Cognition Disorders; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Radioimmunoassay; Severity of Illness Index; Somatostatin | 1993 |